The effect of HIV exposure and infection on immunity to TB in children
HIV暴露和感染对儿童结核病免疫力的影响
基本信息
- 批准号:10535514
- 负责人:
- 金额:$ 7.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-10 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:Activities of Daily LivingAddressAdultAggressive courseBacille Calmette-Guerin vaccinationCD4 Positive T LymphocytesCellsCessation of lifeCharacteristicsChildChildhoodChromatinClinicalCohort StudiesCryopreservationDNADataDevelopmentDiseaseEpigenetic ProcessGenus MycobacteriumHIVHIV InfectionsHIV antiretroviralHIV/TBHeterochromatinHigh PrevalenceImmuneImmune responseImmunityImmunizeInfantInfant MortalityInfectionInflammatory Response PathwayInnate Immune ResponseKenyaLifeLongitudinal cohortMediatingMorbidity - disease rateMycobacterium tuberculosisNatural Killer CellsNeonatalNeonatal MortalityNewborn InfantPediatric cohortPeripheral Blood Mononuclear CellPhenotypePopulations at RiskPredispositionPrevalenceReportingRiskSiteSpecimenTechnologyTestingTrainingTuberculosisUmbilical Cord BloodVaccinationVirusadaptive immune responseantiretroviral therapyco-infectioncofactorcohortepigenomeinfant infectioninfection riskinsightmonocytemortalitymycobacterialnovelpathogenpathogenic bacteriapathogenic funguspathogenic viruspediatric human immunodeficiency virusprenatal exposurepreventive interventionrepositoryresponsetranscriptometuberculosis immunity
项目摘要
Project Summary / Abstract
Over one million new cases of tuberculosis (TB) and 239,000 TB-related deaths occur in children each year.
Despite evidence that HIV exposure in children is associated with a markedly increased risk of infection with
Mycobacterium tuberculosis (Mtb) and development of TB disease, few studies have explored mechanisms for
HIV-related susceptibility to TB in children. HIV-exposed uninfected children (HEU) are exposed in utero to
both maternal HIV and anti-retroviral therapy (ART) and these exposures may influence subsequent immune
responses to Mtb. In settings with high prevalence of HIV and TB, newborns typically receive BCG vaccination
within the first few days of life, which confers some protection against severe forms of TB in young children.
Interestingly, BCG vaccination has also been recognized to confer non-specific beneficial effects, including
reduced neonatal and infant mortality. Moreover, vaccination with BCG is associated with enhanced innate
immune responses to mycobacteria as well as heterologous pathogens, a phenomenon termed “trained
immunity”. Epigenetic reprogramming of innate immune cells, including monocytes and NK cells, is one
mechanism identified that contributes to BCG-induced trained immunity. The effect of maternal HIV exposure
and infant HIV infection on induction of trained immunity to Mtb in BCG-vaccinated infants has not been
described. Our studies will characterize innate and adaptive immune responses to mycobacteria, cofactors
such as ART that may influence immune responses, and the implications of these immune responses for
susceptibility to pediatric Mtb infection. We will test the hypotheses that (1) maternal HIV exposure and infant
HIV infection dampen induction of trained immunity to Mtb via epigenetic reprogramming of innate immune
cells in BCG-vaccinated infants; and (2) ART enhances innate and adaptive anti-mycobacterial immune
responses in HIV-infected children and that deficits in anti-mycobacterial immunity will predict acquisition of
Mtb infection. Using clinically-well characterized longitudinal cohorts of infants and children in Kenya, we will
perform a comprehensive analysis of the phenotype, function, epigenome and transcriptome of innate immune
responses in HEU, HIV-infected, and HIV-unexposed uninfected infants. We will then determine the capacity of
ART to restore innate and adaptive anti-mycobacterial immune responses in HIV-infected children and identify
immune correlates that predict acquisition of Mtb infection. These studies will provide unprecedented insights
into mechanisms of HIV-associated modulation of immunity to Mtb in infants and children and will inform novel
TB preventive interventions in these at-risk populations.
项目摘要/摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Cheryl Liane Day其他文献
Cheryl Liane Day的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Cheryl Liane Day', 18)}}的其他基金
Emory/Georgia TB Research Advancement Center (TRAC)
埃默里/佐治亚州结核病研究促进中心 (TRAC)
- 批准号:
10429403 - 财政年份:2022
- 资助金额:
$ 7.06万 - 项目类别:
Emory/Georgia TB Research Advancement Center (TRAC)
埃默里/佐治亚州结核病研究促进中心 (TRAC)
- 批准号:
10596180 - 财政年份:2022
- 资助金额:
$ 7.06万 - 项目类别:
The effect of HIV infection on CD4 T cell immunity to Mycobacterium tuberculosis
HIV感染对结核分枝杆菌CD4 T细胞免疫的影响
- 批准号:
10385760 - 财政年份:2021
- 资助金额:
$ 7.06万 - 项目类别:
The effect of HIV infection on CD4 T cell immunity to Mycobacterium tuberculosis
HIV感染对结核分枝杆菌CD4 T细胞免疫的影响
- 批准号:
10161129 - 财政年份:2021
- 资助金额:
$ 7.06万 - 项目类别:
The effect of HIV exposure and infection on immunity to TB in children
HIV暴露和感染对儿童结核病免疫力的影响
- 批准号:
10314021 - 财政年份:2019
- 资助金额:
$ 7.06万 - 项目类别:
The effect of HIV exposure and infection on immunity to TB in children
HIV暴露和感染对儿童结核病免疫力的影响
- 批准号:
10094048 - 财政年份:2019
- 资助金额:
$ 7.06万 - 项目类别:
The effect of HIV exposure and infection on immunity to TB in children
HIV暴露和感染对儿童结核病免疫力的影响
- 批准号:
10540681 - 财政年份:2019
- 资助金额:
$ 7.06万 - 项目类别:
NK cell-mediated regulation of T cell immunity in TB/HIV co-infection
TB/HIV 共感染中 NK 细胞介导的 T 细胞免疫调节
- 批准号:
8707104 - 财政年份:2014
- 资助金额:
$ 7.06万 - 项目类别:
Mechanisms of Immune Regulation in Mycobacterium Tuberculosis Infection
结核分枝杆菌感染的免疫调节机制
- 批准号:
8317962 - 财政年份:2009
- 资助金额:
$ 7.06万 - 项目类别:
Mechanisms of Immune Regulation in Mycobacterium Tuberculosis Infection
结核分枝杆菌感染的免疫调节机制
- 批准号:
7688178 - 财政年份:2009
- 资助金额:
$ 7.06万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 7.06万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 7.06万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 7.06万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 7.06万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 7.06万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 7.06万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 7.06万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 7.06万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 7.06万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 7.06万 - 项目类别:
Research Grant














{{item.name}}会员




